Thrombotic microangiopathy associated with cetuximab, an epidermal growth factor receptor inhibitor

Cetuximab is a chimeric human-murine monoclonal antibody that binds competitively and with high affinity to the epidermal growth factor receptor (EGFR) and is used to treat advanced squamous cell carcinoma of the head and neck. After receiving a total of six doses of cetuximab, a 72-year-old male pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nephrology 2017-01, Vol.87 (2017) (1), p.51-54
Hauptverfasser: Koizumi, Mitsuteru, Takahashi, Masahiro, Murata, Maki, Kikuchi, Yuko, Seta, Koichi, Yahata, Kensei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!